A Self-Assembling Short Amphiphilic Peptide And Related Methods And Uses
20220127565 · 2022-04-28
Inventors
Cpc classification
C12N5/0606
CHEMISTRY; METALLURGY
C07K5/0808
CHEMISTRY; METALLURGY
A61K9/06
HUMAN NECESSITIES
C07K11/00
CHEMISTRY; METALLURGY
A61K9/0024
HUMAN NECESSITIES
A61P17/02
HUMAN NECESSITIES
C12N2539/00
CHEMISTRY; METALLURGY
C07K5/0821
CHEMISTRY; METALLURGY
International classification
Abstract
There is provided a self-assembly amphiphilic peptide having the formula (I): XYZ (I), wherein X is a polar moiety at the N-terminus; X and Z each independently has between 1 to 4 residues of aliphatic amino acids or analogs or derivatives thereof, and wherein the average degree of hydrophobicity of the residues in block Z is more than the average degree of hydrophobicity of the residues in block Y. Disclosed are compositions and hydrogel comprising the peptide thereof. Also disclosed are methods of treatment for tissue regeneration, wound healing and methods of culture of stem cells, tissues and organoids.
Claims
1. An amphiphilic peptide having the formula (I):
XYZ (I) wherein X is a polar moiety at the N-terminus; Y and Z each independently has between 1 to 4 residues of aliphatic amino acids or analogs or derivatives thereof, and wherein the average degree of hydrophobicity of the residues in block Z is more than the average degree of hydrophobicity of the residues in block Y.
2. The amphiphilic peptide of claim 1, wherein the polar moiety is selected from the group consisting of a polar functional group, a polar amino acid, and a small polar biomolecule.
3. The amphiphilic peptide of claim 1, wherein the polar moiety is selected from the group consisting of a polar functional group, a polar amino acid, and a small polar biomolecule, wherein the polar functional group is selected from the group consisting of amine, acetyl, hydroxyl, thiol, maleimide, and acid; or the polar amino acid is selected from the group consisting of lysine, histidine, glycine, serine and aspartic acid; or the small polar biomolecule is selected from the group consisting of biotin, alcohol, and saccharide.
4. The amphiphilic peptide of claim 1, wherein the amphiphilic peptide comprises a depsipeptide analog.
5. The amphiphilic peptide of claim 1, wherein the amphiphilic peptide comprises a depsipeptide analog, wherein depsipeptide analog comprises an α-hydroxy acid analog.
6. The amphiphilic peptide of claim 1, wherein the N-terminus is acetylated and/or C-terminus is amidated.
7. The amphiphilic peptide of claim 1, wherein the aliphatic amino acids comprise D-amino acids.
8. The amphiphilic peptide of claim 1, wherein the chirality of each of the residues in Z is the same.
9. The amphiphilic peptide of claim 1, wherein Z comprises a residue of an aliphatic amino acid with hydrophobic side chain, or analogs or derivatives thereof.
10. The amphiphilic peptide of claim 1, wherein the amphiphilic peptide is no more than 7 residues in length.
11. The amphiphilic peptide of claim 1, wherein the amphiphilic peptide is capable of self-assembling into a hydrogel.
12. The amphiphilic peptide of claim 1, wherein the amphiphilic peptide is selected from the group consisting of: KVI, KGAVLI, KGAVIL, KGAVIA, RVI, RGAVLI, RGAVIL, RGAVIA, HVI, HGAVLI, HGAVIL, HGAVIA, OrnVI, OrnGAVLI, OrnGAVIL, OrnGAVIA, DapVI, DapGAVLI, DapGAVIL, DapGAVIA, Dab VI, DabGAVLI, DabGAVIL, DabGAVIA, KgAVLI, KGaVLI, KgAVIL, KGaVIL; KGAVLI-NH.sub.2, KGAVIL-NH.sub.2, KgAVLI-NH.sub.2, KGaVLI-NH.sub.2, KgAVIL-NH.sub.2, and KGaVIL-NH.sub.2; Ac-KVI-NH.sub.2, Ac-KGAVLI-NH.sub.2, Ac-KGAVIL-NH.sub.2, Ac-KGAVIA-NH.sub.2, Ac-RVI-NH.sub.2, Ac-RGAVLI-NH.sub.2, Ac-RGAVIL-NH.sub.2, Ac-RGAVIA-NH.sub.2, Ac-HVI-NH.sub.2, Ac-HGAVLI-NH.sub.2, Ac-HGAVIL-NH.sub.2, Ac-HGAVIA-NH.sub.2, Ac-OrnVI-NH.sub.2, Ac-OrnGAVLI-NH.sub.2, Ac-OrnGAVIL-NH.sub.2, Ac-OrnGAVIA-NH.sub.2, Ac-DapVI-NH.sub.2, Ac-DapGAVLI-NH.sub.2, Ac-DapGAVIL-NH.sub.2, Ac-DapGAVIA-NH.sub.2, Ac-DabVI-NH.sub.2, Ac-DabGAVLI-NH.sub.2, Ac-DabGAVIL-NH.sub.2, Ac-DabGAVIA-NH.sub.2, Ac-KgAVLI-NH.sub.2, Ac-KGaVLI-NH.sub.2, Ac-KgAVIL-NH.sub.2, Ac-KGaVIL-NH.sub.2; GAVLI, SGAVLI, SGAVIL, SGAVIA, TGAVLI, TGAVIL, TGAVIA, SGAVLI, SGAVIA, SgAVLI, SGaVLI, SgAVIA, and SGaVIA; SGAVLI-NH.sub.2, SGAVIA-NH.sub.2, SgAVLI-NH.sub.2, SGaVLI-NH.sub.2, SgAVIA-NH.sub.2, and SGaVIA-NH.sub.2; Ac-GAVLI-NH.sub.2, Ac-SGAVLI-NH.sub.2, Ac-SGAVIL-NH.sub.2, Ac-SGAVIA-NH.sub.2, Ac-TGAVLI-NH.sub.2, Ac-TGAVIL-NH.sub.2, Ac-TGAVIA-NH.sub.2, Ac-SgAVLI-NH.sub.2, Ac-SGaVLI-NH.sub.2, Ac-SgAVIA-NH.sub.2, Ac-SGaVIA-NH.sub.2; DVI, DGAVLI, DGAVIL, EVI, EGAVLI, EGAVIL, and EGAVIA; and Ac-DVI-NH.sub.2, Ac-DGAVLI-NH.sub.2, Ac-DGAVIL-NH.sub.2, Ac-EVI-NH.sub.2, Ac-EGAVLI-NH.sub.2, Ac-EGAVIL-NH.sub.2, and Ac-EGAVIA-NH.sub.2, wherein Orn=ornithine, Dap=2,3-diaminopropionic acid, Dab=2,4-diaminobutyric acid, g=glycolic acid and a=L-lactic acid.
13. The amphiphilic peptide of claim 1 comprised in a composition or a hydrogel.
14. The amphiphilic peptide of claim 1, wherein amphiphilic peptide has one or more properties selected from the group consisting of: stable, biocompatible, biodegradable, biomimetic, xenofree, injectable, thixotrophic, substantially non-mutagenic, substantially resistant to enzymatic degradation, responsive to stimulus, responsive to change in pH, responsive to change in salt concentration, responsive to change in temperature, compatible with bioprinting and has a storage modulus of at least 1 kPa.
15. (canceled)
16. A method of treating a subject in need of tissue regeneration, the method comprising administering the amphiphilic peptide of claim 1 or a composition or a hydrogel comprising the amphiphilic peptide into the subject in need thereof.
17. (canceled)
18. A method of cell, tissue or organoid culture, the method comprising: culturing the cell, the tissue or the organoid in contact with the amphiphilic peptide of claim 1, or a composition or a hydrogel of the amphiphilic peptide.
19. The amphiphilic peptide of claim 1, wherein the amphiphilic peptide is comprised in a hydrogel and when single cells are seeded on or in the hydrogel, the hydrogel is more capable of promoting cell migration and/or generating single colony as compared to a hydrogel composed of peptides having sequences that are inverted from the sequences of said amphiphilic peptide.
20. The amphiphilic peptide of claim 1 when used in culturing stem cell, tissue or organoid.
Description
BRIEF DESCRIPTION OF FIGURES
[0133]
[0134]
[0135]
[0136]
[0137]
[0138]
[0139]
[0140]
[0141]
EXAMPLES
[0142] Example embodiments of the disclosure will be better understood and readily apparent to one of ordinary skill in the art from the following discussions and if applicable, in conjunction with the figures. It should be appreciated that other modifications related to structural, electrical and optical changes may be made without deviating from the scope of the invention. Example embodiments are not necessarily mutually exclusive as some may be combined with one or more embodiments to form new exemplary embodiments.
Materials and Methods
[0143] Materials. All peptides used in this study were either synthesized by solid-phase peptide synthesis, purified using high-performance liquid chromatography mass spectrometry and lyophilized, or purchased from Bachem AG (Bubendorf, Switzerland). Human H1 and H9 embryonic stem cells were purchased from WiCell Research Institute (Madison, Wis.). Reagents for culture of human embryonic stem cells were purchased from Stem Cell Technologies (British Columbia, Canada). All other cell culture reagents were purchased from Life Technologies (Carlsbad, Calif.). For immunohistochemistry, the primary antibodies used were Ab19857 rabbit polyclonal IgG against Oct 4 (Abcam, Cambridge, Mass.), SC-21705 mouse monoclonal IgM against Tra-I-60 (Santa Cruz Biotechnology Inc, Dallas, Tex.), AF1924-SP goat polyclonal IgG against human Sox17 (R&D Systems, USA), MAB2400-SP rabbit monoclonal IgG against human FoxA2 (R&D Systems, USA) and, MAB3665-SP mouse monoclonal IgG against human Cdx2 (R&D Systems, USA). 4′,6-diamidino-2-phenylindole (DAPI) (Invitrogen, Carlsbad, Calif.) was used to stain the actin cell nuclei.
[0144] Preparation of Hydrogels.
[0145] Lyophilized peptide powder was dissolved in milliQ water and mixed for 30 seconds by vortexing to obtain a homogenous solution. 10% volume of 10-times phosphate-buffered saline was subsequently added and mixed by pipetting. Gelation occurred between seconds (PBS) to overnight (water), depending on the peptide concentration and solution used.
[0146] Circular Dichroism Spectroscopy.
[0147] CD spectra were collected with a Jasco CD spectrophotometer fitted with a temperature controller, using quartz suprasil cuvettes with an optical path length of 1 mm. All samples were prepared in milIQ water and equilibrated for an hour at room temperature before measurement. Data acquisition was performed for wavelength range from 190-260 nm with a spectral bandwidth of 1.0 nm. All spectra were baseline-corrected using milliQ water as baseline. The mean residue ellipticity (MRE) was calculated as follows:
[0148] [θ]=θ/(10.Math.N.Math.c.Math.l) where 8 represents the ellipticity in millidegrees, N the number of amino acid residues, c the molar concentration in mol.Math.L-1, and I the cell path length in cm.
[0149] Field Emission Scanning Electron Microscopy.
[0150] Hydrogel samples were flash frozen in liquid nitrogen and subsequently freeze-dried. Lyophilized samples were sputtered with platinum in a JEOL JFC-1600 High Resolution Sputter Coater. The coated sample was then examined with a JEOL JSM-7400F FESEM system using an accelerating voltage of 2-5 kV.
[0151] Rheology.
[0152] Hydrogel samples were prepared in polydimethysiloxane moulds to obtain approximately 1 mm thick, 8 mm diameter discs. Dynamic strain and oscillatory frequency sweep experiments were carried out using the ARES-G2 Rheometer (TA Instruments, Piscataway, N.J.) with 8 mm titanium parallel plate geometry. The readings of 3 samples were averaged for each condition.
[0153] 3D Encapsulation of Stem Cells.
[0154] H1 embryonic stem cells cultured on Matrigel were dissociated into single cells using TrypLE Express, and re-suspended in 50% mTESR in PBS at an approximate concentration of 4×10.sup.6, 10.sup.7 or 1.6×10.sup.7 cells/mL. 0.5 μL of cells was injected into a droplet of 2 μL 10 mg/mL peptide solution. Warmed culture media (mTESR) containing ROCK inhibitor Y-27632 was added for the first day and replaced by either mTESR or endoderm differentiation media subsequently. The endoderm differentiation protocol was adapted from Spence et al (2011). Briefly, the encapsulated cells were exposed to RPMI media containing 100 ng/mL Activin A, 2 mM glutamax, 1% penicillin-streptomycin and increasing concentrations of defined fetal bovine serum. After 3 days, the hydrogel droplets were washed with RPMI and incubated in hindgut differentiation media (RPMI media containing 1% defined fetal bovine serum, 1% penicillin-streptomycin, 2 mM glutamax, 500 ng/mL FGF4 and 500 ng/mL Wnt3A.
[0155] Immunohistochemistry and Confocal Microscopy Imaging.
[0156] Cell samples were fixed in 4% paraformaldehyde for 15 minutes and permeabilized in 0.01% Triton-X for 10 minutes. The encapsulated human embryonic stem cells were incubated at 4° C. overnight in 5% Bovine-Serum Albumin containing primary antibodies. The corresponding secondary antibodies and DAPI were applied for 90 minutes before the samples were imaged. Confocal microscopy was performed using a Zeiss LSM 510 microscope at the Institute of Medical Biology Microscopy Unit (A*STAR, Singapore).
EXAMPLES
[0157] Before the present disclosure, the effect of sequence inversion has never been reported or systematically studied. Because of the strict rules governing the design of self-assembling helical peptides, the directionality change in peptide backbone was expected to disrupt intra-helical hydrogen bonding and thus macromolecular organization. Beta-sheet peptide self-assembly was expected to be affected by a smaller extent due to their characteristic motif of alternating hydrophilic-hydrophobic residues, as well as the planar nature of intermolecular interactions. Almost palindromic beta-sheet sequences have been described.
[0158] Surprisingly, the self-assembly of ultrashort peptides into helical fibers was found to be unaffected by sequence inversion and the consequent reversal in peptide backbone direction. Trimeric and hexameric inverted sequences, exemplified by Ac-KVI-NH.sub.2 and Ac-KGAVLI-NH.sub.2 (
[0159] Interestingly, the inverted sequence with a free N-terminus KGAVLI-NH.sub.2 also undergoes the same conformational transitions (
[0160] The inverted hexapeptide analogs self-assembled into nanofibrous hydrogels (
TABLE-US-00001 TABLE 1 Secondary Minimum gelation Solubility structure concentration in Peptide in water transitions buffered saline Ac-ILVAGK-NH.sub.2 ++ Yes 3 mg/mL Ac-KGAVLI-NH.sub.2 +++ Yes 3 mg/mL KGAVLI-NH.sub.2 +++ Yes 20 mg/mL Ac-IVK-NH.sub.2 ++++ Yes >30 mg/mL Ac-KVI-NH.sub.2 ++++ Yes >30 mg/mL
[0161] The inverted sequence motif demonstrated better solubility in water and similar gelation behavior compared to the original motif. Both motifs demonstrate salt- and pH-enhanced gelation, having lower gelation concentrations in buffered saline. Unlike the original motif, N-terminal acetylation is not a pre-requisite for self-assembly as KGAVLI-NH.sub.2 with its free amine terminus also undergoes the same secondary structure transitions and forms hydrogels in buffered saline. In general, hexamer peptides demonstrate better gelation with lower minimum gelation concentrations.
[0162] The storage moduli of hydrogels prepared in buffered saline are also comparable to Ac-ILVAGK-NH.sub.2 at 10 kPa magnitude (
[0163] Expanding the observations beyond the lysine subclass, representative candidates with acidic and neutral polar moieties were explored. In particular, unlike its Gen-1 counterparts, Ac-DVI-NH.sub.2 bears C-terminus amidation to avoid zwitterion formation (Table 2 and
TABLE-US-00002 TABLE 2 TGA Degradation Peptide [Peptide] .sub.min, water [Peptide] .sub.min, PBS Temperature (° C.) Ac-IVD 40.8 mg/mL 19.2 mg/mL 323.6 Ac-IVD-NH.sub.2 44.9 mg/mL 33.9 mg/mL 328.5 Ac-DVI-NH.sub.2 11.6 mg/mL 9.9 mg/mL 321.5
[0164] The resulting hydrogel is thixotrophic (
[0165] An unexpected advantage of inverting the printable Ac-ILVAGK-NH.sub.2 Gen-1 sequence was improved biological properties for pluripotent stem cell culture. In a time-course study, cell behaviour was tracked in representative hydrogel droplets, and the same hydrogel droplets were imaged for six days. Using Ac-KGAVLI-NH.sub.2 as the matrix for bioprinting hydrogel droplets encapsulating cells, higher retention of the expanding colonies was observed at day 7. Almost all of the hydrogel droplets were intact after 7 days of culture. More interestingly, at threshold cell encapsulation densities exceeding 5×10.sup.6 cells/m L, single cell suspensions of embryonic stem cells H1 and H9 were more likely to aggregate into a single colony when encapsulated in Ac-KGAVLI-NH.sub.2 (
[0166] The example self-assembling sequences are shown in Table 3 below.
TABLE-US-00003 TABLE 3 Basic Neutral Acidic Amino Amino Amino Acid Acid Acid Constituents Constituents Constituents N-terminal Ac-KVI-NH.sub.2 Ac-GAVLI-NH.sub.2 Ac-DVI-NH.sub.2 acetylated Ac-KGAVLI-NH.sub.2 Ac-SGAVLI-NH.sub.2 Ac-DGAVLI-NH.sub.2 Ac-KGAVIL-NH.sub.2 Ac-SGAVIL-NH.sub.2 Ac-DGAVIL-NH.sub.2 Ac-KGAVIA-NH.sub.2 Ac-SGAVIA-NH.sub.2 Ac-EVI-NH.sub.2 Ac-RVI-NH.sub.2 Ac-TGAVLI-NH.sub.2 Ac-EGAVLI-NH.sub.2 Ac-RGAVLI-NH.sub.2 Ac-TGAVIL-NH.sub.2 Ac-EGAVIL-NH.sub.2 Ac-RGAVIL-NH.sub.2 Ac-TGAVIA-NH.sub.2 Ac-EGAVIA-NH.sub.2 Ac-RGAVIA-NH.sub.2 Ac-HVI-NH.sub.2 Ac-HGAVLI-NH.sub.2 Ac-HGAVIL-NH.sub.2 Ac-HGAVIA-NH.sub.2 Ac-OrnVI-NH.sub.2 Ac-OrnGAVLI-NH.sub.2 Ac-OrnGAVIL-NH.sub.2 Ac-OrnGAVIA-NH.sub.2 Ac-DapVI-NH.sub.2 Ac-DapGAVLI-NH.sub.2 Ac-DapGAVIL-NH.sub.2 Ac-DapGAVIA-NH.sub.2 Ac-DabVI-NH.sub.2 Ac-DabGAVLI-NH.sub.2 Ac-DabGAVIL-NH.sub.2 Ac-DabGAVIA-NH.sub.2 Free N- KGAVLI-NH.sub.2 SGAVLI-NH.sub.2 terminus KGAVIL-NH.sub.2 SGAVIA-NH.sub.2 Depsipeptides Ac-KgAVLI-NH.sub.2 Ac-SgAVLI-NH.sub.2 Ac-KGaVLI-NH.sub.2 Ac-SGaVLI-NH.sub.2 KgAVLI-NH.sub.2 SgAVLI-NH.sub.2 KGaVLI-NH.sub.2 SGaVLI-NH.sub.2 Ac-KgAVIL-NH.sub.2 Ac-SgAVIA-NH.sub.2 Ac-KGaVIL-NH.sub.2 Ac-SGaVIA-NH.sub.2 KgAVIL-NH.sub.2 SgAVIA-NH.sub.2 KGaVIL-NH.sub.2 SGaVIA-NH.sub.2
EXAMPLES
Amphiphilic Short Peptide Motif for Wound Healing
[0167] A porcine wound healing study was performed to evaluate the peptide hydrogels for wound healing applications. An 8 cm×8 cm excisional full thickness wound was created on the back of the animal, and three of the peptide hydrogels were applied using a polydimethylsiloxane mould. Wound dressing changes were carried out weekly for 6 weeks, with application of fresh hydrogel. The results point towards an effective reduction of wound size for all three peptides tested (i.e. P1: Ac-HGAVLI-NH.sub.2; P2: SGAVLI-NH.sub.2; P3: Ac-KGAVLI-NH.sub.2). Representative images of the original wound sites and appearance after 1, 4 and 6 weeks are shown in
[0168] In recent years, stem cell-derived organoid cultures are increasingly being used as models to study tissue and disease development, and evaluate therapeutic candidates. In particular, the use of patient-derived organoids has revolutionized personalized medicine as they are superior predictive in vitro models. Intestinal organoids prepared from colon biopsies have successfully been used to identify patients who will respond to an experimental cystic fibrosis therapy. The development of such organoid models was boosted by advances in defined growth factor cocktails, which mimic the various stem cell niches. The biochemical cues stimulate the self-organization of cells into structures that partially recapitulate key tissue traits such as the spatial arrangement of heterogeneous cells, cellular interactions and some biological processes. A crucial step for organoid development is the encapsulation of stem cell-derived progenitors or adult stem cells into Matrigel (solubilized basement membrane preparation extracted from murine sarcoma). This suggests that cell-substrate interactions in a 3D microenvironment are integral for cell migration during organoid differentiation. Due to its nanofibrous macromolecular architecture, ultrashort peptide hydrogels would be an ideal substitute for Matrigel. When paired with defined media, peptide hydrogels constitute a completely defined culture environment, free of xenogenic components. Although such a synthetic matrix would be devoid of natural ligands, bioactive motifs can be easily incorporated using various conjugation strategies. This will confer better control over the biochemical makeup of the microenvironment, and predispose differentiation into preferred lineages. As a proof-of-concept, the protocol described by Spence et al. was adapted for the direct 3D differentiation of embryonic stem cells into hindgut spheroids (
[0169] The motif is more important than sequence in dictating the self-assembly of ultrashort peptides. While the physicochemical properties are largely unchanged, sequence inversion of ultrashort self-assembling peptides can have significant effect on its biological properties. Most notably, when used as synthetic 3D stem cell culture substrates, it was observed that Ac-KGAVLI-NH.sub.2 prompted enhanced cell migration and better consistency in generating single colonies for reproducible organoid derivation, compared to its Gen1 analog. Its stimuli-responsive gelation properties can be harnessed for bioprinting, to reproducibly encapsulate cells for organoid differentiation. This scalable and customizable manufacturing technique can be automated for large-scale culture or for generating defined multi-domain tissue constructs for screening therapeutics, studying disease development and elucidating cellular interactions.
[0170] It will be appreciated by a person skilled in the art that other variations and/or modifications may be made to the embodiments disclosed herein without departing from the spirit or scope of the disclosure as broadly described. For example, in the description herein, features of different exemplary embodiments may be mixed, combined, interchanged, incorporated, adopted, modified, included etc. or the like across different exemplary embodiments. The present embodiments are, therefore, to be considered in all respects to be illustrative and not restrictive.
REFERENCE
[0171] 1. Mendes, A. C.; Baran, E. T.; Reis, R. L.; Azevedo, H. S., Self-assembly in nature: using the principles of nature to create complex nanobiomaterials. Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology 2013, 5 (6), 582-612. [0172] 2. Loo, Y.; Zhang, S.; Hauser, C. A., From short peptides to nanofibers to macromolecular assemblies in biomedicine. Biotechnol Adv 2012, 30 (3), 593-603. [0173] 3. (a) Fallas, J. A.; O'Leary, L. E.; Hartgerink, J. D., Synthetic collagen mimics: self-assembly of homotrimers, heterotrimers and higher order structures. Chem Soc Rev 2010, 39 (9), 3510-27; (b) Gauba, V.; Hartgerink, J. D., Self-assembled heterotrimeric collagen triple helices directed through electrostatic interactions. J Am Chem Soc 2007, 129 (9), 2683-90. [0174] 4. (a) Bromley, E. H.; Sessions, R. B.; Thomson, A. R.; Woolfson, D. N., Designed alpha-helical tectons for constructing multicomponent synthetic biological systems. J Am Chem Soc 2009, 131 (3), 928-30; (b) Papapostolou, D.; Smith, A. M.; Atkins, E. D.; Oliver, S. J.; Ryadnov, M. G.; Serpell, L. C.; Woolfson, D. N., Engineering nanoscale order into a designed protein fiber. Proc. Natl. Acad. Sci. USA 2007, 104 (26), 10853-8. [0175] 5. (a) Frederix, P.; Patmanidis, I.; Marrink, S. J., Molecular simulations of self-assembling bio-inspired supramolecular systems and their connection to experiments. Chemical Society reviews 2018, 47 (10), 3470-3489; (b) Makam, P.; Gazit, E., Minimalistic peptide supramolecular co-assembly: expanding the conformational space for nanotechnology. Chemical Society reviews 2018, 47 (10), 3406-3420. [0176] 6. (a) Zhang, S., Emerging biological materials through molecular self-assembly. Biotechnol Adv 2002, 20 (5-6), 321-39; (b) Zhang, S.; Holmes, T.; Lockshin, C.; Rich, A., Spontaneous assembly of a self-complementary oligopeptide to form a stable macroscopic membrane. Proc. Natl. Acad. Sci. USA 1993, 90 (8), 3334-8. [0177] 7. Loo, Y.; Lakshmanan, A.; Ni, M.; Toh, L. L.; Wang, S.; Hauser, C. A., Peptide Bioink: Self-Assembling Nanofibrous Scaffolds for Three-Dimensional Organotypic Cultures. Nano letters 2015, 15 (10), 6919-25. [0178] 8. Hauser, C. A.; Deng, R.; Mishra, A.; Loo, Y.; Khoe, U.; Zhuang, F.; Cheong, D. W.; Accardo, A.; Sullivan, M. B.; Riekel, C.; Ying, J. Y.; Hauser, U. A., Natural tri- to hexapeptides self-assemble in water to amyloid beta-type fiber aggregates by unexpected alpha-helical intermediate structures. Proc Natl Acad Sci USA 2011, 108 (4), 1361-6. [0179] 9. Smadbeck, J.; Chan, K. H.; Khoury, G. A.; Xue, B.; Robinson, R. C.; Hauser, C. A.; Floudas, C. A., De novo design and experimental characterization of ultrashort self-associating peptides. Accounts of chemical research 2014, 10 (7), e1003718. [0180] 10. Clevers, H., Modeling Development and Disease with Organoids. Cell 2016, 165 (7), 1586-1597. [0181] 11. (a) Saini, A., Cystic Fibrosis Patients Benefit from Mini Guts. Cell Stem Cell 19 (4), 425-427; (b) Dekkers, J. F.; Wiegerinck, C. L.; de Jonge, H. R.; Bronsveld, I.; Janssens, H. M.; de Winter-de Groot, K. M.; Brandsma, A. M.; de Jong, N. W.; Bijvelds, M. J.; Scholte, B. J.; Nieuwenhuis, E. E.; van den Brink, S.; Clevers, H.; van der Ent, C. K.; Middendorp, S.; Beekman, J. M., A functional CFTR assay using primary cystic fibrosis intestinal organoids. Nature medicine 2013, 19 (7), 939-45. [0182] 12. Yin, X.; Mead, B. E.; Safaee, H.; Langer, R.; Karp, J. M.; Levy, O., Engineering Stem Cell Organoids. Cell Stem Cell 2016, 18 (1), 25-38. [0183] 13. Spence, J. R.; Mayhew, C. N.; Rankin, S. A.; Kuhar, M. F.; Vallance, J. E.; Tolle, K.; Hoskins, E. E.; Kalinichenko, V. V.; Wells, S. I.; Zorn, A. M.; Shroyer, N. F.; Wells, J. M., Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro. Nature 2011, 470 (7332), 105-9.
APPLICATIONS
[0184] Peptide self-assembly is driven by secondary structure and intermolecular interactions, which are in turn dictated by peptide sequence. In view of the strict rules governing the design of helical self-assembling motifs, it is surprising that the self-assembly of ultrashort peptides into helical fibers is found to be unaffected by sequence inversion and the consequent reversal in peptide backbone direction.
[0185] During self-assembly, trimeric and hexameric inverted sequences are observed to undergo the same secondary structure transitions as their parent sequences, forming rigid, nanofibrous hydrogels in physiologically buffered saline. The results suggest that motif is more important than sequence in dictating the self-assembly of ultrashort peptides.
[0186] While the physicochemical properties are largely unchanged, sequence inversion of ultrashort self-assembling peptides can have significant effect on its biological properties. Most notably, when used as synthetic 3D stem cell culture substrates, it was observed that Ac-KGAVLI-NH.sub.2 prompted enhanced cell migration and consistency in generating single colonies for organoid derivation, compared to Ac-ILVAGK-NH.sub.2. In view of its reproducibility and printability, this new subset of self-organizing nanobiomaterials is well-positioned to facilitate the bioengineering of scalable and customizable in vitro tissue models.